Welcome message for NAFLD Summit 2019
On behalf of The European Association for the Study of the Liver (EASL), it gives me great pleasure to invite you to join us at the EASL Non-Alcoholic Fatty Liver Disease (NAFLD) Summit 2019. The meeting will be held on 26-28 September 2019 in Seville, Spain.
NAFLD is the leading cause of chronic liver disease, not only in Western countries, but also amongst many other developed and developing countries.
Indeed, in the US and Europe, nearly 40% of the population have NAFLD and approximately 20% are likely to develop progressive liver disease that leads to liver fibrosis and cirrhosis.
At EASL, we are committed to helping clinicians, researchers and students network with various stakeholders in the field of hepatology, providing the opportunity to share research and learn from peers across Europe and beyond.
NAFLD Summit attendees will learn and discuss new developments and challenges in NAFLD, including how the development of new therapies is urgently needed in this arena. To maximise exposure with attendees at the NAFLD Summit and enrich the meeting experience, companies are invited to participate as conference partners. Here, organisations can benefit from a variety of partnership packages, which include premium, bespoke and individual sponsorship and engagement opportunities.
Our dedicated team will provide you with all the support required to achieve and maximise your conference and communications objectives, ensuring a successful Summit and a smooth experience.
We look forward to welcoming you to the city of Seville in September.
EASL Secretary General
Topic to be covered at the NAFLD Summit 2019
- Multidisciplinary management of patients with NAFLD
- Need for better patient stratification in NAFLD therapeutic trials
- Prevention of NAFLD and public Health strategies
- Diagnostic methodologies in NAFLD
- Pre-clinical models of NAFLD/NASH to test drug efficacy
Scientific Organising Committee
- Prof. Isabelle Leclercq
- Prof. Massimo Pinzani
- Prof. Manuel Romero-Gomez
- Dr Joern Schattenberg
Find out more on the NAFLD 2019 website.
“The NAFLD Summit 2019, Sevilla, Spain, 26/09/2019-28/09/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 13 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”
“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
Each participant can only receive the number of credits he/she is entitled to according to his/her actual participation at the event once he/she has completed the feedback form. Cf. criteria 9 and 23 of UEMS 2016.20.
In order to help you issue individual certificates to each participants, please find below the breakdown of ECMEC®s per day:
26.09.2019 – 3.00
27.09.2019 – 7.00
28.09.2019 – 3.00
The EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8 ECMEC®s per day. Cf. Chapter X of UEMS 2016.20.
The event is supported by an unrestricted education grant from Abbvie. Abbvie has had no input into the contents of the programme and website.
See all NAFLD summit 2019 sponsors and exhibitors.